Grades of Hepatic Encephalopathy and Their Management
Hepatic encephalopathy (HE) should be classified according to the West Haven criteria when temporal disorientation is present (grades ≥2), with the Glasgow Coma Scale added for grades III-IV, while neuropsychological or neurophysiological testing should be used to diagnose covert HE in patients with mild or no neuropsychiatric abnormalities. 1
Classification of Hepatic Encephalopathy
Types of HE
- Type A: Due to acute liver failure 1
- Type B: Due to portosystemic shunt without significant liver disease 1
- Type C: Due to cirrhosis with or without portosystemic shunt 1
Severity Grading (West Haven Criteria)
Overt HE: Includes Grades II-IV 1
Time Course Classification
- Episodic: Single episode 1
- Recurrent: More than one episode over a 6-month period 1
- Persistent: No return to normal/baseline neuropsychiatric performance between episodes 1
Management Approach by Grade
General Management Principles
- A four-pronged approach is recommended for all grades of HE 1:
- Initiation of care for patients with altered consciousness
- Identification and treatment of alternative causes of altered mental status
- Identification and correction of precipitating factors
- Commencement of empirical HE treatment
Management of Covert HE (Minimal and Grade I)
- Testing for covert HE should be considered in patients with impaired quality of life, employment implications, or public safety concerns 1
- Treatment is not routinely recommended but may be considered in specific circumstances affecting daily functioning 1, 3
- Avoid sedatives when possible as they can worsen encephalopathy 3
Management of Grade II HE
- Can typically be managed on a medicine ward 3
- Lactulose is recommended as first-line treatment, titrated to achieve 2-3 soft stools per day 3
- Identify and correct precipitating factors (infections, GI bleeding, constipation, dehydration, electrolyte disturbances) 1, 3
Management of Grade III-IV HE
- Requires intensive care monitoring due to risk of airway compromise 1
- Add Glasgow Coma Scale assessment for monitoring 1
- More aggressive investigation and management of precipitating factors 5
- Lactulose administration (may require nasogastric tube in patients unable to swallow) 1
- Consider rifaximin as add-on therapy for patients with recurrent episodes 3
Important Clinical Considerations
Diagnostic Approach
- Brain imaging (CT/MRI) should be performed to exclude other causes of altered mental status, particularly for first-time HE 1
- Blood ammonia levels alone do not add diagnostic, staging, or prognostic value; a normal value should prompt diagnostic reevaluation 1
- For research purposes, diagnosis of covert HE requires at least two validated testing strategies: paper-pencil tests (PHES) plus either computerized tests or neurophysiological tests 1
Treatment Recommendations
- An episode of overt HE should be actively treated 1
- Secondary prophylaxis after an episode of overt HE is recommended 1
- Primary prophylaxis is not required except in patients with cirrhosis at high risk for developing HE 1
- Recurrent intractable overt HE, together with liver failure, is an indication for liver transplantation 1
Common Pitfalls to Avoid
- Failing to identify and treat precipitating factors, which account for nearly 90% of cases 1, 3
- Relying solely on ammonia levels for diagnosis or monitoring 1, 3
- Not considering secondary prophylaxis after the first episode of overt HE 3
- Inadequate titration of lactulose dosage to achieve 2-3 soft stools per day 3
- Confusing hepatic encephalopathy with other causes of altered mental status 3